Reached agreement with FDA on pivotal study design for TSC-101 following productive end of Phase 1 meetingData from ALLOHA™ Phase 1 heme trial to ...

Presented initial data from Phase 1b study suggesting GT-02287 has a disease-slowing effect consistent with the preclinical ...

Skilled nursing providers bracing for validation audits should prepare for medical record requests sooner rather than later.

Goldman's head of AI engineering for asset management, Dan Popescu, tells Business Insider what makes candidates stand out.

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the third quarter 2025 and provided an update on the company’s recent developments.

The Novel Allosteric NEK7 Inhibitor Ofirnoflast (HT-6184) Demonstrates Robust and Sustained Hematologic Response in Subjects with IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndrome ...

Detailed price information for Serina Therapeutics Inc (SER-A) from The Globe and Mail including charting and trades.

Nick Saban continues to be linked to major college football coaching jobs despite the "College GameDay" legend insisting he ...

A new payment model for family doctors in Manitoba has proven effective at retaining and recruiting physicians to the ...

Q3 2025 Earnings Call Transcript November 4, 2025 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1 ...